The total cost of astrocytoma treatment in Turkey varies depending on the treatment plan. Initial diagnostics, including a consultation, laboratory tests, and MRI with contrast, are approximately $1,850. Surgical removal of the tumor ranges from $18,000 to $28,000, while postoperative radiotherapy with temozolomide is around $7,000. The treatment program is personalized, following an individual assessment by the medical team.
| Turkey | Austria | Spain | |
| Stereotaxic radiosurgery | from $4,500 | from $17,000 | from $12,000 |
| Radiation therapy for colorectal cancer | from $7,000 | from $12,000 | from $10,000 |
| Craniotomy | from $6,450 | from $20,000 | from $25,000 |
| Chemotherapy for breast cancer | from $1,200 | from $15,000 | from $3,500 |
Specializes in tumor biology and immunotherapy – Dr. Bülent Karagöz focuses on advanced cancer treatments at Anadolu Medical Center.
Dr. Tanrikulu has served as the head of Haydarpaşa Numune's medical oncology unit and is an active researcher in international clinical trials.
Dr. Solak specializes in treating astrocytoma with extensive training from Hacettepe University Cancer Institute and MD Anderson Cancer Center.
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.